Back to search

Charco Neurotech Ltd

12028625

active
Private Limited Company
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Going concern doubt noted in accounts (-10)

Details

WELLINGTON HOUSE, CAMBRIDGE, CB1 1BH
Incorporated 03/06/2019

Compliance

Last accounts

28/02/2025

total exemption full

Next accounts due

30/11/2026

On track

Confirmation statement

Last: 01/06/2026

Due 15/06/2027

On track

Industry

32500
Manufacture of medical and dental instruments and supplies
72200
Research and experimental development on social sciences and humanities

Officers

Parkwalk Advisors Ltd

director · Since 29/09/2021

Also on 44 other boards

Mr Pierre Robert Socha

director · Since 29/09/2021

INVESTOR

FRENCH · UNITED KINGDOM · Age 47

Also on 5 other boards

Charles Edward Alvarez

director · Since 16/12/2022

CEO, STRATUS NEURO

AMERICAN · UNITED STATES · Age 59

Also on 1 other board

Mr Andrew Mullen

director · Since 30/03/2026

BRITISH · ENGLAND · Age 59

Persons with Significant Control

Mnl (Parkwalk) Nominees Limited

ownership-of-shares-25-to-50-percent-as-firm
voting-rights-25-to-50-percent-as-firm

3, Pancras Square, London, N1C 4AG

Reg: 13166311 · Mnl (Parkwalk) Nominees Limited · Limited Company

Notified 20/02/2024

Former PSCs

Ms Soo Min Jung

Ceased 30/01/2024

Dr Floyd Pierres

Ceased 04/09/2020

CompanyRankvs 252+ SIC 32500 peers
68

Financial strength91th percentile among SIC peers · 23/25
Employees87th percentile among SIC peers · 13/15
LiquidityCurrent ratio 8× · 20/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

Act 2006. The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £. 2.2. Going Concern Disclosure The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern

Key FinancialsYear ending 28/02/2026

Net Worth

£971k

Balance sheet strength

Cash

£560k

Cash in the bank

Net Current Assets

£823k

Working capital

Current Assets

£940k

Current Liabilities

£118k

Fixed Assets

£148k

Debtors

£211k

10avg. employees-12

Tax at Year End(2023)

Corp tax-£258k

Director Loans(2024)

Directors owe company£96

Balance Sheet

Intangible assets£56k
Assets less current liabilities£971k
Signed by Mr Andrew Mullen 13 July 2026Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20268.00-£4.0M
202411.25+£1.3M
202343.06

Derived from filed accounts. Not audited figures.